Of particular note, the significance of 1p/19q codeletion [17-19] and mutation of isocitrate dehydrogenase 1 or 2 (IDH1-mt or IDH2-mt) [17,19-21] has recently been established with regard to the prediction of the prognosis of gliomas. Here, IDH1 is linked to central nervous system cancer.